APR 02, 2015 10:06 AM PDT

Versatile Smart Phone Diagnosis?

WRITTEN BY: Judy O'Rourke
Similar to the way glucometers and pregnancy tests have revolutionized in-home diagnostic testing, researchers from Florida Atlantic University (FAU) and collaborators from Harvard Medical School and the Stanford School of Medicine have identified a new biosensing platform that could be used to remotely detect and decide on treatment options for HIV, E. coli, Staphylococcus aureus, and other bacteria.

Using a drop of blood from a fingerprick, this biosensing platform provides clinically relevant specificity, sensitivity, and detection of pathogens from whole blood and plasma, the researchers say.
Thin, lightweight, flexible materials developed by researchers at Florida Atlantic University, Stanford, and Harvard, integrate cellulose paper and flexible polyester films as new diagnostic tools to detect bioagents in whole blood, serum, and peritoneal fluid.
"There is a dire need for robust, portable, disposable, and inexpensive biosensing platforms for clinical care, especially in developing countries with limited resources," says Waseem Asghar, PhD, assistant professor of electrical engineering, College of Engineering and Computer Science, FAU, co-first author on the study. "Existing paper and flexible material-based platforms use colorimetric, fluorometric, and electrochemical approaches that require complex labeling steps to amplify their signal, are very costly to fabricate, and also require expensive equipment and infrastructure."

In a recent article, the researchers address the limitations of available paper and flexible material-based platforms and discuss how they have integrated cellulose paper and flexible polyester films as new diagnostic tools to detect bioagents in whole blood, serum, and peritoneal fluid. They employed three different paper and flexible material-based platforms incorporated with electrical and optical sensing modalities, and demonstrate how these new materials can be widely applied to a variety of settings including medical diagnostic and biology laboratories.

Thin, lightweight, and flexible materials developed by the team can be fabricated and operated without the need for costly infrastructure and skilled personnel, potentially helping to solve real-world healthcare problems for developed and developing countries.

Using this technology, they have also developed a phone app that could detect bacteria and disease in the blood using images from a cellphone that could easily be analyzed from anywhere in the world.

This methodology offers a new, rapid, and cost-effective way to diagnose diseases and monitor treatment in point-of-care settings, and these new platforms are able to isolate and detect multiple biotargets selectively, sensitively, and repeatedly from diverse biological mediums using antibodies.

"The future of diagnostics and health monitoring will have potentially cell-phone based or portable readers sipping saliva or blood and continuously monitoring human health, taking it way beyond where we are with counting steps today," says Utkan Demirci, PhD, Stanford School of Medicine, who is the corresponding author.

Demirci notes that these platforms could potentially be adapted and tailored to detect other pathogens and biotargets with well-known biomarkers.

"Our paper microchip technologies can potentially have a significant impact on infectious diseases management in low- and middle-income countries where there is limited laboratory infrastructure," says Hadi Shafiee, PhD, instructor in medicine, Division of Biomedical Engineering, Brigham and Women's Hospital, Harvard Medical School.

The article is "Paper and Flexible Substrates as Materials for Biosensing Platforms to Detect Multiple Biotargets," published in Nature Scientific Reports.

[Source: Florida Atlantic University]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 12, 2020
Drug Discovery & Development
In vitro glycoengineering - Suitability for BioPharma manufacturing
OCT 12, 2020
In vitro glycoengineering - Suitability for BioPharma manufacturing
Introduction The importance of Fc glycosylation of monoclonal antibodies (mAbs) with regard to biological activity is wi ...
OCT 13, 2020
Neuroscience
Sleep Apnea and Alzheimer's Damage Brain in Same Way
OCT 13, 2020
Sleep Apnea and Alzheimer's Damage Brain in Same Way
Sleep apnea is characterized by breathing that repeatedly stops and starts, loud snoring, restless sleep, and sleepiness ...
OCT 13, 2020
Cell & Molecular Biology
A Small Part of the Brain May Transmit Inflammation From Mom to Fetus
OCT 13, 2020
A Small Part of the Brain May Transmit Inflammation From Mom to Fetus
There is still a lot we don't know about the brain, and especially about two small bits of tissue deep within it called ...
OCT 21, 2020
Cell & Molecular Biology
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
OCT 21, 2020
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
During a heart attack, blood flow is blocked and cells lose oxygen and begin to die. Scientists are developing many new ...
OCT 29, 2020
Health & Medicine
Endocannabinoids Block Pathogenic Bacteria That Cause Gut Ailments in Mouse Study
OCT 29, 2020
Endocannabinoids Block Pathogenic Bacteria That Cause Gut Ailments in Mouse Study
Cannabis users have long reported, anecdotally, that the drug can ease gastrointestinal woes, including irritable bowel ...
Loading Comments...